Fennec Pharmaceuticals (FENC) Invested Capital (2010 - 2025)

Fennec Pharmaceuticals (FENC) has 16 years of Invested Capital data on file, last reported at $35.5 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital rose 187.6% year-over-year to $35.5 million; the trailing twelve-month figure through Dec 2025 stood at $35.5 million (up 187.6% YoY), and the FY2025 full-year result was $35.5 million, up 187.6% from the prior year.
• Invested Capital for Q4 2025 stood at $35.5 million, up from $13.7 million in the prior quarter.
• Across five years, Invested Capital topped out at $35.5 million in Q4 2025 and bottomed at $2.8 million in Q3 2022.
• The 5-year median for Invested Capital is $18.0 million (2023), against an average of $19.1 million.
• The widest annual swing landed in 2022, when Invested Capital slumped 88.33%; it then jumped 416.38% in 2023.
• A 5-year view of Invested Capital shows it stood at $20.8 million in 2021, then grew by 7.99% to $22.4 million in 2022, then slipped by 18.07% to $18.4 million in 2023, then sank by 32.89% to $12.3 million in 2024, then surged by 187.6% to $35.5 million in 2025.
• The last three Invested Capital figures came in at $35.5 million (Q4 2025), $13.7 million (Q3 2025), and $10.7 million (Q2 2025), per Business Quant data.

Peer Comparison